|
|
||||||||
Biology of Reproduction, Vol 25, 1159-1168, Copyright © 1981 by Society for the Study of Reproduction
1 Department of Obstetrics and Gynecology, Department of Biochemistry, and
Department of Anatomy,
Vanderbilt University School of Medicine,
Nashville, Tennessee 37232 We have previously shown that the administration of estrogens to intact adult male guinea pigs
resulted in a variety of morphological changes in their accessory sex organs (the seminal vesicles,
prostate, common ejaculatory chamber, coagulating gland, and epididymis). To ascertain if a biochemical basis existed for a direct action of estrogens on these tissues, we examined them for the
presence of estrogen receptors. We determined that cytosol prepared from the accessory sex glands
contains a macromolecular binding component for estradiol-17
. This component sediments as an
8S species on 5-20% sucrose gradients under low (0.01 M KCl) ionic strength conditions and as
a 4S species under high (0.4 M KCl) ionic strength conditions. Time-course studies indicate that
binding equilibrium is achieved in
2 h; dissociation of [3H] estradiol from the binding protein is
very slow (t
>42 h). The cytoplasmic binder is highly specific for estrogens; the relative affinities
of various estrogens for the protein were estradiol = 1, estrone = 0.72, diethylstilbestrol 0.30, and
estriol = 0.17. Progesterone, testosterone, and 5
-dihydrotestosterone, even at a 1000-fold excess,
caused less than 10% inhibition of [3H] estradiol binding to the protein. The binder present in
cytosol prepared from the accessory sex organs (excluding the epididymis) exhibited an equilibrium dissociation constant of
0.3 nM, and there were
30 fmoles of binding sites per mg of
cytosol protein. The cytoplasmic estrogen binder exhibits the characteristics usually attributed to
receptors and is clearly different from a 4S, nonspecific, rapidly dissociating binder that is present
in plasma. On the basis of steroid specificity, the cytoplasmic estrogen binder is distinct from the
androgen receptor that is present in male reproductive tissues.
Note:
ACKNOWLEDGMENTS
This research was supported by NIH grants HD
11706, HD 08295, HD 05797 (Population Center),
and RR 05424 (BRSG). The authors wish to thank
Ms. Esther Thomas for her excellent technical assistance and Ms. Vera Henley for typing the manuscript.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |